Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase I trial in Europe and sub-Saharan Africa

Projectdetails

Beschrijving

The overall objective of Vacc-iNTS is to bridge the gap between preclinical and early clinical development of a novel vaccine against invasive non-typhoidal salmonellosis (iNTS), based on GMMA (Generalized Modules for Membrane Antigens) technology and to conduct a Phase I study to demonstrate safety and immunogenicity of the iNTS-GMMA candidate vaccine in healthy European and African adults.
AcroniemVacc-iNTS
StatusVoltooid
Effectieve start/einddatum1/10/1931/03/21

Financiering

  • European Commission: 31.296,56 €